Article Details
Retrieved on: 2024-08-30 17:50:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Seeking to bolster its CDMO business, Bora Pharmaceuticals is acquiring an approximate 30.5% stake in Taiwanese drug maker Tanvex BioPharma.
Article found on: www.bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here